Home › Funds › Hartford › Hartford Healthcare HLS Fund
Fund family: Hartford · Filed by HARTFORD SERIES FUND INC (CIK 1053425) · SEC series S000003206
Share classes and tickers: HBGHX (C000008599), HIAHX (C000008598)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 789 with, 15 against, 0 abstentions (not counted as with management); 11 items carried no recommendation. Shareholder proposals: 5 FOR, 10 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Hartford’s manager page (71,105 ballot items across 52 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Hartford | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 97.6% | 719 | 92.9% | 55,674 |
| Backed environmental and social shareholder proposals at US companies | n/a | 6 | 15.0% | 968 |
Each ballot item this fund voted is set against the votes of the other Hartford funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most Hartford funds on all 413 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 72.3% of this fund’s 804 such votes could be given a sector; the other 223 (27.7%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 519 | 14 | 2.7% |
| Industrials | 45 | 0 | 0.0% |
| Consumer Staples | 17 | 1 | 5.9% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 486 | 0 |
| Audit-related | 85 | 0 |
| Say-on-Pay | 71 | 0 |
| Corporate Governance | 64 | 5 |
| Compensation | 50 | 0 |
| Capital Structure | 45 | 0 |
| Shareholder Rights and Defenses | 12 | 4 |
| Other Social Issues | 7 | 4 |
| Diversity, Equity, and Inclusion | 1 | 1 |
| Human Rights or Human Capital/workforce | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Eli Lilly and Company | May 4, 2026 | $19M | 10 | 2 |
| Merck & Co., Inc. | May 26, 2026 | $8M | 18 | 3 |
| Johnson & Johnson | April 23, 2026 | $7M | 15 | 1 |
| UnitedHealth Group Incorporated | June 1, 2026 | $7M | 12 | 1 |
| AbbVie Inc. | May 8, 2026 | $5M | 8 | 1 |
| Edwards Lifesciences Corporation | May 7, 2026 | $4M | 12 | 0 |
| Danaher Corporation | May 5, 2026 | $4M | 14 | 0 |
| Intuitive Surgical, Inc. | April 30, 2026 | $4M | 13 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | For | Against |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| April 23, 2026 | Johnson & Johnson | Independent Board Chair Shareholder proposal | Against | For |
| June 1, 2026 | UnitedHealth Group Incorporated | If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposal | Against | For |
| May 8, 2026 | AbbVie Inc. | Stockholder proposal - to adopt a policy to require an independent chair Shareholder proposal | For | Against |
| May 13, 2026 | Vertex Pharmaceuticals Incorporated | Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposal | For | Against |
| May 13, 2026 | Elevance Health, Inc. | Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. Shareholder proposal | Against | For |
| May 14, 2026 | CVS Health Corporation | Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposal | Against | For |
| April 23, 2026 | HCA Healthcare, Inc. | Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences. Shareholder proposal | Against | For |
| April 23, 2026 | HCA Healthcare, Inc. | Stockholder proposal, if properly presented at the meeting, regarding shareholders' right to act by written consent. Shareholder proposal | Against | For |
These funds reported the same votes as Hartford Healthcare HLS Fund in the latest season (or all but a few items), so they share this page:
822 ballot items at 83 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Hartford Healthcare HLS Fund (HBGHX) voted at 83 shareholder meetings of 79 companies, on 822 ballot items in all. Where management made a recommendation, the fund followed it on 98.1% of the items and voted against it 15 times. Its most frequent area of disagreement was corporate governance (5 of its votes against management). It voted on 15 shareholder proposals. It voted FOR the board's own proposals more often than Hartford's funds as a whole (97.6% against 92.9%). It voted the same way as most Hartford funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Hartford’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.